SK

Sashi Kiran Kode

Active Director Managing Director DIN 01562875
DIN 01562875 First appointment Jul 2007 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Jul 2007
Shareholding value •••• Premium profile

About Sashi Kiran Kode

Data last updated:

Sashi Kiran Kode has 19 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including D2l Pharma Research Solutions Private Limited and N9 Pharmaceuticals Private Limited. Formerly with 5 companies, such as D2l Clinical Solutions Private Limited and Igen Labs Private Limited. Engaged in General Business, Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹8.70 Cr; the largest is D2l Pharma Research Solutions Private Limited at ₹8.09 Cr (FY 2025).

DIN 01562875
Primary Designation Managing Director
First Appointment 06 Jul 2007
Oldest Company Age 19 yrs
Largest company D2l Pharma Research Solutions Private Limited · ₹8.09 Cr (FY 2025)
Combined revenue ₹8.70 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director06 Jul 20072007₹8.09 Cr (FY 2025)Active
Managing Director19 Feb 20142014₹60.7 Lakh (FY 2020)Active
N9 Pharmaceuticals Private Limited U24290TG2022PTC166282
Director02 Sep 20222022–Active
Alx Biotech Private Limited U24303KA2019PTC128930
Director19 Oct 20192019–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director15 Jul 20142014₹12.5 Lakh (FY 2025)Active
Igen Labs Private Limited U73100TG2009PTC064748
Director14 Aug 20092009–Strike Off
Director14 Dec 20112011–Strike Off
Director17 Jul 20092009₹1.5 Lakh (FY 2014)Strike Off
Designated Partner07 Jan 20142014–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
D2l Pharma Research Solutions Private Limited
N9 Pharmaceuticals Private Limited
Alx Biotech Private Limited
Arunachalamm Renewable Energy Private Limited
Premium access

Shareholding and investment profile for Sashi Kiran Kode

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sashi Kiran Kode

Sashi Kiran Kode has 19 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including D2l Pharma Research Solutions Private Limited and N9 Pharmaceuticals Private Limited. Formerly with 5 companies, such as D2l Clinical Solutions Private Limited and Igen Labs Private Limited. Engaged in General Business, Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹8.70 Cr; the largest is D2l Pharma Research Solutions Private Limited at ₹8.09 Cr (FY 2025).

Sashi Kiran Kode is associated with 4 companies as Managing Director and Director, including D2l Pharma Research Solutions Private Limited (₹8.09 Cr), Arunachalamm Renewable Energy Private Limited (₹60.7 Lakh), N9 Pharmaceuticals Private Limited.

Sashi Kiran Kode has expertise in General Business, Technology.

Sashi Kiran Kode has 19 years in corporate governance.

By reported revenue, the largest current company of Sashi Kiran Kode is D2l Pharma Research Solutions Private Limited, with revenue of ₹8.09 Cr (FY 2025).

The 2 current companies of Sashi Kiran Kode that report revenue have a combined latest revenue of ₹8.70 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available